Healthcare Press

Transfer RNAs at the heart of therapeutic resistance

  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 8 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 53%

Skin Cancer News

Personalized Medicine,Gene Therapy,Diabetes

Scientists have discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies. Inhibition of the VARS enzyme could prevent this therapeutic resistance by resensitizing tumors resistant to these targeted therapies.

An international research team led by scientists from the University of Liège has discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies. Inhibition of the VARS enzyme could prevent this therapeutic resistance by resensitising tumours resistant to these targeted therapies.

* Targeted therapies are new forms of cancer treatment that exploit the biological differences between cancer cells and healthy cells in the body.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 452. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Scientists create tailored drug for aggressive breast cancerScientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
Source: ScienceDaily - 🏆 452. / 53 Read more »